MedTech Europe takes part in a Joint Industry Statement on the AI Act
Posted on 02.03.2023
On 23 February, MedTech Europe, together with 13 other industry associations such as Business Europe, published a stakeholder letter addressed to Members of the European Parliament calling for further deliberation of seven key principles. Among others, stakeholders call to maintain the risk-based approach of the original proposal while defining ‘high-risk’ in a way that reflects it and to ensure that the AI Act does not overlap and creates competing obligations with existing legislation. Furthermore, calling for the use of an AI definition that is recognised by industry and in line with OECD work and that does not include non-AI tools. Read the full statement here.
For more information, please contact Simone Mohrs, Manager Digital Health.